Theramir Ltd

Theramir Ltd

Biotechnology Research

Developing novel microRNA based therapeutics and companion diagnostics for patients and healthcare providers

About us

Theramir’s proprietary technologies are based on microRNAs (miRNAs), a class of small non-coding RNAs that can regulate multiple genes and pathways associated with cancer growth and metastasis. The company has developed a panel of miRNAs, both biological and synthetic, which can affect the function and disrupt expression of an expanding list of oncoproteins that are dysregulated in most cancer types. Thus, our technologies can be applied to the development of novel targeted therapeutics that may potentially transform the precision oncology field by creating new knowledge on the pathology of the disease and by enabling the customization and personalization of cancer treatment.

Website
http://www.theramir.com
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Limassol
Type
Privately Held
Founded
2016
Specialties
miRNA, biotechnology, cancer research, stem cells, nanoparticles, exosomes, and liquid biopsy

Locations

Employees at Theramir Ltd

Updates

Similar pages

Browse jobs